1 Institute of Clinical Medicine, University of Aarhus, Denmark; The Royal Hospital, Muscat, Oman. Electronic address: eskildp@dadlnet.dk.
2 Therapeutic Immunology (TIM) Division, Department of Laboratory Medicine, Karolinska University Hospital Huddinge, and Centre for Allogeneic Stem Cell Transplantation, Karolinska University Hospital Huddinge, Stockholm, Sweden. Electronic address: Markus.Maeurer@ki.se.
3 The Children's Hospital at Westmead and Centre for Research Excellence in Tuberculosis (TB-CRE), Marie Bashir Institute for Infectious Diseases and Biosecurity (MBI), University of Sydney, Australia. Electronic address: ben.marais@sydney.edu.au.
4 WHO Collaborating Centre for TB and Lung Diseases, Maugeri Care and Research Institute, Tradate, Italy. Electronic address: gbmigliori@gmail.com.
5 UNZA-UCLMS Research and Training Project, University Teaching Hospital, Lusaka, Zambia. Electronic address: pbmwaba2000@gmail.com.
6 Fondation Congolaise pour la Recherche Médicale, Faculté des Sciences de la Santé, Marien Ngouabi University, Brazzaville, Congo; Institute for Tropical Medicine, University of Tübingen, Tübingen, Germany. Electronic address: fntoumi@fcrm-congo.com.
7 Unitat de Tuberculosi Experimental Fundació Institut d'Investigació en Ciències de la Salut Germans Trias i PujolEdifici Laboratoris de Recerca Can Ruti Campus, Barcelona, Spain. Electronic address: cvilaplana@gmail.com.
8 Department of Medicine (Infectious Diseases), of Microbiology & Immunology and of Pathology, Albert Einstein College of Medicine, Bronx, NY, USA. Electronic address: kami.kim@einstein.yu.edu.
9 Critical Path to TB Drug Regimens, Critical Path Institute, Tucson, Arizona, USA. Electronic address: mschito@c-path.org.
10 Center for Clinical Microbiology, Division of Infection and Immunity, University College London, and the National Institute of Health Research Biomedical Research Centre at UCLHospitals, London, United Kingdom. Electronic address: a.zumla@ucl.ac.uk.